Preclinical and phase I clinical studies with Ckd-602, a novel camptothecin derivative (Q73476651)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 January 2000
edit
Language Label Description Also known as
English
Preclinical and phase I clinical studies with Ckd-602, a novel camptothecin derivative
scientific article published on 01 January 2000

    Statements

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit